181 related articles for article (PubMed ID: 35132181)
1. Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis.
Liao CG; Liang XH; Ke Y; Yao L; Liu M; Liu ZK; He L; Guo YX; Bian H; Chen ZN; Kong LM
Oncogene; 2022 Mar; 41(12):1780-1794. PubMed ID: 35132181
[TBL] [Abstract][Full Text] [Related]
2. Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth.
Yang B; Tang H; Wang N; Gu J; Wang Q
Cell Death Dis; 2023 Mar; 14(3):210. PubMed ID: 36966142
[TBL] [Abstract][Full Text] [Related]
3. miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma.
He B; Chen J; Song W; Bai Y
Genomics; 2021 May; 113(3):1469-1481. PubMed ID: 33667646
[TBL] [Abstract][Full Text] [Related]
4. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
8. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
9. Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome.
Sagvekar P; Shinde G; Mangoli V; Desai SK; Mukherjee S
Mol Hum Reprod; 2022 Jun; 28(7):. PubMed ID: 35640568
[TBL] [Abstract][Full Text] [Related]
10. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
11. Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export.
Wang K; Huang W; Chen R; Lin P; Zhang T; Ni YF; Li H; Wu J; Sun XX; Geng JJ; Zhu YM; Nan G; Zhang W; Chen X; Zhu P; Bian H; Chen ZN
Cell Metab; 2021 Jan; 33(1):160-173.e6. PubMed ID: 33406400
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
Liu XH; Lu KH; Wang KM; Sun M; Zhang EB; Yang JS; Yin DD; Liu ZL; Zhou J; Liu ZJ; De W; Wang ZX
BMC Cancer; 2012 Aug; 12():348. PubMed ID: 22876840
[TBL] [Abstract][Full Text] [Related]
13. miR-26a-5p Suppresses Wnt/
Yu J; Ge Z; Chen S; Li S; Zhang X; Hu J; Guo W; Wang Y
Dis Markers; 2022; 2022():7926483. PubMed ID: 35860691
[TBL] [Abstract][Full Text] [Related]
14. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
17. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
Yu M; Li D; Cao W; Chen X; Du W
Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
19. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
20. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.
Mastoraki S; Balgkouranidou I; Tsaroucha E; Klinakis A; Georgoulias V; Lianidou E
Mol Oncol; 2021 Sep; 15(9):2412-2422. PubMed ID: 33159839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]